Prostate Cancer
The economics of abiraterone acetate for castration-resistant prostate cancer - Abstract
March 26, 2014
Baseline selenium status and effects of selenium and vitamin E supplementation on prostate cancer risk - Abstract
March 25, 2014
The use of androgen deprivation therapy (ADT) and chemotherapeutic agents in New Zealand men with prostate cancer - Abstract
March 25, 2014
An update on occupation and prostate cancer - Abstract
March 25, 2014
Radiation safety considerations for the use of (223)RaCl(2) DE in men with castration-resistant prostate cancer - Abstract
March 25, 2014
Salvage therapy for castration-refractory prostate cancer resistant to docetaxel - Abstract
March 25, 2014
Diffusion-weighted MRI as a predictor of extracapsular extension in prostate cancer - Abstract
March 24, 2014
The Postoperative Morbidity Index: A quantitative weighing of postoperative complications applied to urological procedures - Abstract
March 24, 2014